Shiovitz, T., Greenberg, W. M., Chen, C., Forero, G., & Gommoll, C. P. (2014). A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder. Matrix Medical Communications.

Shiovitz, Thomas, William M. Greenberg, Changzheng Chen, Giovanna Forero, and Carl P. Gommoll. A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients With Major Depressive Disorder. Matrix Medical Communications, 2014.

Shiovitz, Thomas, et al. A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients With Major Depressive Disorder. Matrix Medical Communications, 2014.